| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |